Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14779
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Radchatawedchakoon W. | |
dc.contributor.author | Watanapokasin R. | |
dc.contributor.author | Krajarng A. | |
dc.contributor.author | Yingyongnarongkul B.-e. | |
dc.date.accessioned | 2021-04-05T03:37:11Z | - |
dc.date.available | 2021-04-05T03:37:11Z | - |
dc.date.issued | 2010 | |
dc.identifier.issn | 9680896 | |
dc.identifier.other | 2-s2.0-72149112492 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14779 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-72149112492&doi=10.1016%2fj.bmc.2009.10.057&partnerID=40&md5=f1a09ff986602cf0a9e30304b768f92e | |
dc.description.abstract | Twenty-four asymmetric divalent head group cholesterol-based cationic lipids were designed and synthesized by parallel solid phase chemistry. These asymmetric head groups composed of amino functionality together with trimethylamino, di(2-hydroxyethyl)amino or guanidinyl groups. Spacers between cationic heads and linker were both equal and unequal in length. These lipids were subjected to evaluation for DNA binding affinities by gel retardation assay and were screened for their transfection efficiency on HEK293 cells. Cationic lipids with equal chain length exhibited high transfection efficiency when polar part contained asymmetric polar heads. In contrast, lipids with unequal chain length exhibited high transfection efficiency when polar part contained symmetric heads. According to the optimal formulation, seven lipids exhibited higher transfection efficiency than the commercially available transfection agents, Effectene™, DOTAP and DC-Chol, to deliver DNA into PC3 human prostate adenocarcinoma cells. 3β-[N-(N′-Guanidinyl)-2′-aminoethyl)-N-(2-aminoethyl)ca rbamoyl] cholesterol (5) bearing amino and guanidinyl polar heads exhibited highest transfection efficiency with minimal toxicity. The morphology of active liposomes was observed by transmission electron microscopy (TEM) and size of liposomes were around 200-700 nm. © 2009 Elsevier Ltd. All rights reserved. | |
dc.subject | 3b [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (2' aminoethyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (3' aminopropyl) n [n glycine[n (2 aminoethyl) amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (3' aminopropyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine [n (3 aminopropyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine[n (2 aminoethyl)amide]] carbamoyl]cholesterol | |
dc.subject | 3beta [n (n' guanidinyl) 2' aminoethyl n (2 aminoethyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n (n',n' di(2'' hydroxyethyl) 3' aminopropyl) n (3 aminopropyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n' guanidinyl) 2' aminoethyl] n (2 aminoethyl) carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n' guanidinyl) 3' aminopropyl] n (3 aminoproyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n (2 amino ethyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n (3 aminopropyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (3 aminopropyl)amide]]carbamoyl] cholesterol | |
dc.subject | 3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n (2 aminoethyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol | |
dc.subject | 3beta [n,n (2,2' diaminoethyl)carbamoyl]cholesterol | |
dc.subject | 3beta [n,n (3,3' diaminopropyl)carbamoyl]cholesterol | |
dc.subject | cholesterol derivative | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | carbon nuclear magnetic resonance | |
dc.subject | controlled study | |
dc.subject | DNA binding | |
dc.subject | DNA transfection | |
dc.subject | drug design | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | gene targeting | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | prostate adenocarcinoma | |
dc.subject | proton nuclear magnetic resonance | |
dc.subject | solid phase synthesis | |
dc.subject | transmission electron microscopy | |
dc.subject | Binding Sites | |
dc.subject | Cations | |
dc.subject | Cell Line | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cholesterol | |
dc.subject | DNA | |
dc.subject | Humans | |
dc.subject | Lipids | |
dc.subject | Liposomes | |
dc.subject | Phosphatidylethanolamines | |
dc.subject | Serum | |
dc.subject | Transfection | |
dc.title | Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Bioorganic and Medicinal Chemistry. Vol 18, No.1 (2010), p.330-342 | |
dc.identifier.doi | 10.1016/j.bmc.2009.10.057 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.